Use of acid e.g. citric acid or esp. glutamic acid hydrochloride for treatment of hepatic encephalopathy
DE4441763A1
Treatment of hepatic encephalopathy with salt of branched aminoacid
DE3814910A1
Process for the preparation of lipoid ethylcellulose gels and pharmaceutical, cosmetic and industrial use thereof
DE3605345A1
Use of organic salts of diflunisal in a cutaneous administration form
DE3602434A1
Use of solid fatty acid glycerides as aids for reducing particle size and the use of size-reduced products for pharmaceutical formulations
DE3340872A1
Production of absorption-promoting aqueous ointment gels from polyacrylic acid or methacrylic acid copolymers using urea as gel former
DE3306042A1
Process for the acylation of functional groups, in organic compounds, which can be acylated
DE3229937A1
Method for the optimisation of the solidification properties of fatty compositions
DE3221579A1
Solubilisation of active substances, which are sparingly soluble in water, in aqueous solution using a mixture of cholinephosphoric acid glycerol diester (choline-lecithin) and sodium deoxycholate as solubiliser, and the therapeutic use of the aqueous solutions obtained thereby
DE3138836A1
Organic salts of tolmetin, their preparation and pharmaceuticals containing them
DE3110460A1
Sodium salt of benzarone sulphuric acid ester, its preparation and pharmaceutical compositions prepared from this compound
DE3049445A1
Heparin and heparinoid salts with organic bases - e.g. aliphatic amine(s) or di:hydro-ergotamine
DE3038690A1
Pharmaceutically active heparin salts - are prepd. by reacting heparin with di:hydro:ergotamine or a prim. or sec. aliphatic amine
DE3020220A1
Heparin and heparinoid salts with organic bases - e.g. di:ethylamine, tri:ethanolamine, tri:ethylamine or buphenine
DE3015530A1
Gastric juice resistant gelatin capsules prodn. - by treatment with a soln. of phthalic-aldehyde, isophthalic-aldehyde or terephthalic-aldehydic acid
DE2946234A1
Increasing sensitivity of fluorescence and/or absorption measuring - using reflective surface as support for separating thin layer in high performance chromatography
DE2942281A1
Increasing sensitivity of absorbing and/or fluorescent substances - using support plates with aluminium vapour deposition and silicon oxide fixation
DE2936436A1
Mefenamic and niflumic acids salts with organic bases - e.g. di:ethylamine, tri:ethanolamine or tri:ethylamine with improved absorption after cutaneous, oral or rectal admin.
DE2935776A1
Indomethacin, naproxen and diclofenac salts - with organic bases, esp. di:ethylamine, tri:ethanol-amine or tri:ethylamine
DE2922866A1
Thin layer chromatography using fluorimetric analysis - where sepg. agents are located on mirrors to increase sensitivity of fluorescence measurements
